Monash IVF Group Ltd (AU:MVF)
ASX:MVF
Want to see AU:MVF full AI Analyst Report?
MVF Stock Chart & Stats
AU$0.76
AU$0.00(0.00%)
At close: 4:00 PM EST
AU$0.76
AU$0.00(0.00%)
Day’s Range― - ―
52-Week RangeAU$0.54 - AU$0.90
Previous CloseN/A
Volume300.99K
Average Volume (3M)2.18M
Market Cap
AU$284.43M
Enterprise ValueAU$566.24M
Total Cash (Recent Filing)AU$8.14M
Total Debt (Recent Filing)AU$281.81M
Price to Earnings (P/E)10.0
Beta1.20
Next Earnings
Aug 26, 2026EPS Estimate
0.02Next Dividend Ex-DateN/A
Dividend Yield6.22%
Share Statistics
EPS (TTM)0.02
Shares Outstanding389,634,830
10 Day Avg. Volume1,374,502
30 Day Avg. Volume2,181,726
Financial Highlights & Ratios
PEG Ratio-0.02
Price to Book (P/B)1.12
Price to Sales (P/S)1.01
P/FCF Ratio588.64
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
AU$0.81Price Target Upside6.14% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering6
EPS Forecast (FY)0.05
Revenue Forecast (FY)AU$267.04M
Bulls Say, Bears Say
Bulls Say
Integrated Clinic And Laboratory NetworkAn integrated clinic-plus-lab model creates durable competitive advantages: better clinical coordination, lower per-cycle costs, and improved outcomes that support referral relationships. Scale across clinics and labs also helps utilization and margin stability over the medium term.
Healthy Profit Margins And Recent Revenue JumpSustained gross and net margins indicate pricing power and cost control in clinical services, supporting cash generation and reinvestment. The recent large revenue lift, if structural, improves ability to cover fixed lab and clinic costs, enhancing long-term profitability.
Moderate Leverage With Positive ROEA balanced debt-to-equity ratio and double-digit ROE suggest the company uses leverage prudently to drive returns. This capital structure supports investment in clinic capacity and labs without excessive refinancing risk, helping sustain growth initiatives over time.
Bears Say
Sharp Decline In Free Cash FlowA near-total collapse in free cash flow materially reduces financial flexibility: it constrains capital expenditure, M&A, and dividend capacity, and may force reliance on debt or equity. Persistently weak cash conversion risks long-term investment and operational plans.
Volatile Revenue TrendInconsistent top-line trends create forecasting and planning risk for clinics whose revenue depends on patient volumes and treatment mix. Volatility can pressure utilisation, staffing and fixed-cost absorption, making margin and cash outcomes less predictable over the coming months.
Demand Sensitivity To Reimbursement And ReferralsRevenue dependence on public and private reimbursement and clinician referral networks exposes the business to policy shifts and external partner behaviour. Changes in funding rules or referral patterns could materially alter patient affordability and volumes over a multi-month horizon.
Monash IVF Group Ltd News
MVF FAQ
What was Monash IVF Group Ltd’s price range in the past 12 months?
Monash IVF Group Ltd lowest share price was AU$0.54 and its highest was AU$0.90 in the past 12 months.
What is Monash IVF Group Ltd’s market cap?
Monash IVF Group Ltd’s market cap is AU$284.43M.
When is Monash IVF Group Ltd’s upcoming earnings report date?
Monash IVF Group Ltd’s upcoming earnings report date is Aug 26, 2026 which is in 121 days.
How were Monash IVF Group Ltd’s earnings last quarter?
Monash IVF Group Ltd released its earnings results on Feb 25, 2026. The company reported AU$0.018 earnings per share for the quarter, missing the consensus estimate of AU$0.025 by -AU$0.007.
Is Monash IVF Group Ltd overvalued?
According to Wall Street analysts Monash IVF Group Ltd’s price is currently Undervalued.
Does Monash IVF Group Ltd pay dividends?
Monash IVF Group Ltd pays a Semiannually dividend of AU$0.026 which represents an annual dividend yield of 6.22%. See more information on Monash IVF Group Ltd dividends here
What is Monash IVF Group Ltd’s EPS estimate?
Monash IVF Group Ltd’s EPS estimate is 0.02.
How many shares outstanding does Monash IVF Group Ltd have?
Monash IVF Group Ltd has 389,634,830 shares outstanding.
What happened to Monash IVF Group Ltd’s price movement after its last earnings report?
Monash IVF Group Ltd reported an EPS of AU$0.018 in its last earnings report, missing expectations of AU$0.025. Following the earnings report the stock price went up 2.954%.
Which hedge fund is a major shareholder of Monash IVF Group Ltd?
Currently, no hedge funds are holding shares in AU:MVF
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Monash IVF Group Ltd Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
AU$0.81 (6.14% Upside)
AU$0.81 (6.14% Upside)
Blogger Sentiment
Bullish
AU:MVF Sentiment 94%
Sector Average 72%
Sector Average 72%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-37.39%
12-Months-Change
Fundamentals
Return on Equity
6.06%
Trailing 12-Months
Asset Growth
0.49%
Trailing 12-Months
Company Description
Monash IVF Group Ltd
Monash IVF Group Limited provides assisted reproductive and specialist women imaging services in Australia and Malaysia. The company offers diagnostic obstetric, gynecological ultrasound, and fertility treatment services. It also provides tertiary level prenatal diagnostic and IVF treatment services. The company was incorporated in 2014 and is based in Richmond, Australia.
MVF Stock 12 Month Forecast
Average Price Target
AU$0.81
▲(6.14% Upside)
Technical Analysis
Healius Limited
―
Sonic Healthcare Limited
―
Integral Diagnostics Ltd.
―
Australian Clinical Labs Ltd
―
Options Prices
Currently, No data available
---